Northrop Grumman Corporation (NOC) Financial Statements
Northrop Grumman Corporation (NOC) reported trailing twelve-month revenue of $43.6B (up 6.5% year on year) and net income of $4.5B as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $3.8B.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
NOCNorthrop Grumman CorporationFollow NOC — free
—
Price chart with a free account
- Market cap
- 78.3B
- P/E TTM
- 17.4
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 25 Jan, in 93 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.65 | 28.14 | 26.41 | 25.22 | 24.66 | 23.98 | 23.53 | 24.51 | 25.80 | 30.10 | 33.84 | 36.80 | 35.67 | 36.60 | 39.29 | 41.03 | 41.95 | 43.59 | |
| Gross profit | 15.00 | 15.59 | 14.92 | 14.80 | 14.04 | 13.55 | 13.19 | 13.51 | 13.53 | — | — | — | — | — | — | — | — | — | |
| Research & development | — | 0.58 | 0.54 | 0.52 | 0.51 | 0.57 | 0.71 | 0.71 | 0.64 | 0.76 | 0.95 | 1.10 | 1.10 | 1.20 | 1.20 | 1.10 | 1.10 | — | |
| Operating income | 2.27 | 2.83 | 3.28 | 3.13 | 3.12 | 3.20 | 3.08 | 3.28 | 3.22 | 3.78 | 3.97 | 4.07 | 5.65 | 3.60 | 2.54 | 4.37 | 4.51 | 4.63 | |
| Pre-tax income | 2.07 | 2.37 | 3.08 | 2.97 | 2.86 | 2.94 | 2.79 | 2.68 | 4.23 | 3.74 | 2.55 | 3.73 | 8.94 | 5.84 | 2.35 | 5.02 | 5.07 | 5.24 | |
| Income tax | 0.64 | 0.46 | 1.00 | 0.99 | 0.91 | 0.87 | 0.80 | 0.64 | 1.36 | 0.51 | 0.30 | 0.54 | 1.93 | 0.94 | 0.29 | 0.84 | 0.89 | 0.72 | |
| Net income | 1.69 | 2.05 | 2.12 | 1.98 | 1.95 | 2.07 | 1.99 | 2.04 | 2.87 | 3.23 | 2.25 | 3.19 | 7.01 | 4.90 | 2.06 | 4.17 | 4.18 | 4.52 | |
| Diluted EPS ($) | 5.21 | 6.82 | 7.52 | 7.81 | 8.35 | 9.75 | 10.39 | 11.32 | 16.34 | 18.49 | 13.22 | 19.03 | 43.54 | 31.47 | 13.53 | 28.34 | 29.08 | 31.67 | |
| Diluted shares (bn) | 0.323 | 0.301 | 0.282 | 0.253 | 0.234 | 0.212 | 0.192 | 0.180 | 0.176 | 0.175 | 0.170 | 0.168 | 0.161 | 0.156 | 0.152 | 0.147 | 0.144 | — |
USD billions · SEC XBRL
Northrop Grumman Corporation — questions
- What is Northrop Grumman Corporation's revenue?
- $43.6B over the twelve months to 2026-09-30, up 6.5% year on year, from its 10-Q and 10-K filings.
- What is Northrop Grumman Corporation's net income?
- $4.5B over the twelve months to 2026-09-30.
- What is Northrop Grumman Corporation's free cash flow?
- $3.8B over the twelve months to 2026-09-30.
- What are Northrop Grumman Corporation's diluted earnings per share?
- $31.67 over the twelve months to 2026-09-30.
Every figure on this page comes from Northrop Grumman Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.